<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0004818'>Paroxysmal nocturnal hemoglobinuria</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) is a unique disorder caused by a PIG-A gene mutation in a stem cell clone </plain></SENT>
<SENT sid="1" pm="."><plain>Its clinical picture can sometimes make challenging the distinction from other disorders, and especially from <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), since both diseases correlate with cytopenias and morphological abnormalities of bone marrow (BM) cells </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, flow cytometry (FC) has been proposed to integrate the morphologic assessment of BM <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and thus to improve the diagnostics of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: In the present study, we have analyzed systematically FC data resulting from the study of BM cells from patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Our data demonstrated abnormalities in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> beyond the deficiency of <z:chebi fb="0" ids="24410">glycosylphosphatidylinositol</z:chebi>-linked proteins and the application of a systematic approach allowed us to separate effectively <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> in a cluster analysis and to highlight disease-specific abnormalities </plain></SENT>
<SENT sid="5" pm="."><plain>Indeed, the parallel evaluation of some key parameters, i.e. patterns of expression of CD45 and CD10, provided information with practical diagnostic usefulness in the distinction between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, the hypo-expression of CD36 that we observed on monocytes might be related to the thrombotic tendency in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: We investigated systematically the phenotypic profile of BM cells from patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>; our data provide useful antigenic patterns to solve between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, sometimes morphologically overlapping </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, some <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>-related phenotypic changes might be involved in the physiopathology of the disease and further studies addressing this issue are warranted </plain></SENT>
</text></document>